(Q39465605)

English

Gefitinib resistance in HCC mahlavu cells: Upregulation of CD133 expression, activation of IGF‐1R signaling pathway, and enhancement of IGF‐1R nuclear translocation

scientific article published on July 1, 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Gefitinib resistance in HCC mahlavu cells: upregulation of CD133 expression, activation of IGF-1R signaling pathway, and enhancement of IGF-1R nuclear translocation (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Gefitinib resistance in HCC mahlavu cells: Upregulation of CD133 expression, activation of IGF‐1R signaling pathway, and enhancement of IGF‐1R nuclear translocation (English)

1 reference

10.1002/JCP.23041

https://api.crossref.org/works/10.1002/JCP.23041

13 December 2024

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Zhengyu Wei

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Reginald Hurtt

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Tina Gu

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Cataldo Doria

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Adam S. Bodzin

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21959795

13 December 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21959795

13 December 2024

publication date

1 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

July 2012

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21959795

13 December 2024

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcp.23041

1 reference

10.1002/JCP.23041

https://api.crossref.org/works/10.1002/JCP.23041

13 December 2024

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.23041

1 reference

10.1002/JCP.23041

https://api.crossref.org/works/10.1002/JCP.23041

13 December 2024

Journal of Cellular Physiology

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

227

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

2947-2952

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FJCP.23041

21 January 2018

IGFBP-3, a marker of cellular senescence, is overexpressed in human papillomavirus-immortalized cervical cells and enhances IGF-1-induced mitogenesis

1 reference

https://api.crossref.org/works/10.1002%2FJCP.23041

21 January 2018

Differentiation and malignant transformation: two roads diverged in a wood

1 reference

https://api.crossref.org/works/10.1002%2FJCP.23041

21 January 2018

The IGF‐1 receptor in cancer biology

1 reference

https://api.crossref.org/works/10.1002%2FJCP.23041

21 January 2018

Primary liver cancer: worldwide incidence and trends

1 reference

https://api.crossref.org/works/10.1002%2FJCP.23041

21 January 2018

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJCP.23041

21 January 2018

Obesity and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJCP.23041

21 January 2018

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

1 reference

https://api.crossref.org/works/10.1002%2FJCP.23041

21 January 2018

Over-accumulation of nuclear IGF-1 receptor in tumor cells requires elevated expression of the receptor and the SUMO-conjugating enzyme Ubc9

1 reference

https://api.crossref.org/works/10.1002%2FJCP.23041

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCP.23041

21 January 2018

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJCP.23041

21 January 2018

Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.23041

21 January 2018

The insulin-like growth factor 1 receptor in cancer: old focus, new future

1 reference

https://api.crossref.org/works/10.1002%2FJCP.23041

21 January 2018

Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FJCP.23041

21 January 2018

CD133 expression in chemo-resistant Ewing sarcoma cells

1 reference

https://api.crossref.org/works/10.1002%2FJCP.23041

21 January 2018

Nuclear localization of EGF receptor and its potential new role as a transcription factor

1 reference

https://api.crossref.org/works/10.1002%2FJCP.23041

21 January 2018

CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.23041

21 January 2018

Resistance mechanisms to cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FJCP.23041

21 January 2018

SUMOylation mediates the nuclear translocation and signaling of the IGF-1 receptor

1 reference

https://api.crossref.org/works/10.1002%2FJCP.23041

21 January 2018

A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations

1 reference

https://api.crossref.org/works/10.1002%2FJCP.23041

21 January 2018

CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.23041

21 January 2018

CD133 suppresses neuroblastoma cell differentiation via signal pathway modification

1 reference

https://api.crossref.org/works/10.1002%2FJCP.23041

21 January 2018

IGF-I receptor signalling in transformation and differentiation

1 reference

https://api.crossref.org/works/10.1002%2FJCP.23041

21 January 2018

Insulin-like growth factor binding proteins IGFBP3, IGFBP4, and IGFBP5 predict endocrine responsiveness in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FJCP.23041

21 January 2018

Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FJCP.23041

21 January 2018

The developing role of receptors and adaptors

20

1 reference

10.1002/JCP.23041

https://api.crossref.org/works/10.1002/JCP.23041

13 December 2024

Estimating future hepatitis C morbidity, mortality, and costs in the United States

29

1 reference

10.1002/JCP.23041

https://api.crossref.org/works/10.1002/JCP.23041

13 December 2024

Identifiers

10.1002/JCP.23041

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39465605&oldid=2286819004"